WO2005016290A1 - 二酸化炭素外用ゲル調製用組成物と二酸化炭素外用ゲル - Google Patents
二酸化炭素外用ゲル調製用組成物と二酸化炭素外用ゲル Download PDFInfo
- Publication number
- WO2005016290A1 WO2005016290A1 PCT/JP2004/011882 JP2004011882W WO2005016290A1 WO 2005016290 A1 WO2005016290 A1 WO 2005016290A1 JP 2004011882 W JP2004011882 W JP 2004011882W WO 2005016290 A1 WO2005016290 A1 WO 2005016290A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carbon dioxide
- gel
- parts
- composition
- preparing
- Prior art date
Links
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 title claims abstract description 862
- 239000001569 carbon dioxide Substances 0.000 title claims abstract description 431
- 229910002092 carbon dioxide Inorganic materials 0.000 title claims abstract description 431
- 238000002360 preparation method Methods 0.000 title claims abstract description 247
- 239000000203 mixture Substances 0.000 title claims abstract description 239
- 239000000499 gel Substances 0.000 title abstract description 400
- 239000011345 viscous material Substances 0.000 claims abstract description 394
- 239000008187 granular material Substances 0.000 claims abstract description 324
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 180
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims abstract description 173
- 229910001424 calcium ion Inorganic materials 0.000 claims abstract description 173
- 239000002253 acid Substances 0.000 claims abstract description 147
- 239000002516 radical scavenger Substances 0.000 claims abstract description 102
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 101
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 90
- 239000002270 dispersing agent Substances 0.000 claims abstract description 86
- 239000003349 gelling agent Substances 0.000 claims abstract description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 233
- 239000000126 substance Substances 0.000 claims description 92
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 80
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 80
- 239000002245 particle Substances 0.000 claims description 80
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 80
- 239000011230 binding agent Substances 0.000 claims description 76
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 59
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 59
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 59
- 210000004400 mucous membrane Anatomy 0.000 claims description 59
- 239000013618 particulate matter Substances 0.000 claims description 56
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 42
- 235000010413 sodium alginate Nutrition 0.000 claims description 42
- 239000000661 sodium alginate Substances 0.000 claims description 42
- 229940005550 sodium alginate Drugs 0.000 claims description 42
- 239000000853 adhesive Substances 0.000 claims description 39
- 230000001070 adhesive effect Effects 0.000 claims description 39
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 34
- 239000004471 Glycine Substances 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 230000001965 increasing effect Effects 0.000 claims description 11
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 10
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 10
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 8
- 239000011575 calcium Substances 0.000 claims description 8
- 229910052791 calcium Inorganic materials 0.000 claims description 8
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 8
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 5
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 claims description 2
- 238000001879 gelation Methods 0.000 abstract description 21
- 235000019441 ethanol Nutrition 0.000 description 135
- 239000003755 preservative agent Substances 0.000 description 61
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 57
- 239000008101 lactose Substances 0.000 description 57
- 229960001375 lactose Drugs 0.000 description 57
- 230000002335 preservative effect Effects 0.000 description 55
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 53
- 229920001353 Dextrin Polymers 0.000 description 53
- 239000004375 Dextrin Substances 0.000 description 53
- 235000019425 dextrin Nutrition 0.000 description 53
- 238000006243 chemical reaction Methods 0.000 description 47
- 238000002156 mixing Methods 0.000 description 38
- 150000001298 alcohols Chemical class 0.000 description 36
- 239000008213 purified water Substances 0.000 description 36
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 32
- 239000011734 sodium Substances 0.000 description 32
- 229910052708 sodium Inorganic materials 0.000 description 32
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 31
- 239000002537 cosmetic Substances 0.000 description 31
- 229960005323 phenoxyethanol Drugs 0.000 description 31
- 229940043375 1,5-pentanediol Drugs 0.000 description 28
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 28
- 230000007721 medicinal effect Effects 0.000 description 27
- 229920000609 methyl cellulose Polymers 0.000 description 27
- 235000010981 methylcellulose Nutrition 0.000 description 27
- 239000001923 methylcellulose Substances 0.000 description 27
- 229940058015 1,3-butylene glycol Drugs 0.000 description 26
- 238000010521 absorption reaction Methods 0.000 description 26
- 235000019437 butane-1,3-diol Nutrition 0.000 description 26
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 25
- -1 methylene phosphonic acid Chemical compound 0.000 description 20
- 239000002994 raw material Substances 0.000 description 20
- 238000004090 dissolution Methods 0.000 description 19
- 239000012298 atmosphere Substances 0.000 description 14
- 206010015150 Erythema Diseases 0.000 description 13
- 229920002472 Starch Polymers 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 206010052428 Wound Diseases 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 11
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 11
- 238000013329 compounding Methods 0.000 description 11
- 210000000245 forearm Anatomy 0.000 description 11
- 230000002829 reductive effect Effects 0.000 description 11
- 230000008901 benefit Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000008107 starch Substances 0.000 description 10
- 235000010980 cellulose Nutrition 0.000 description 9
- 229920002678 cellulose Polymers 0.000 description 9
- 239000001913 cellulose Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 229920001592 potato starch Polymers 0.000 description 9
- 230000035807 sensation Effects 0.000 description 9
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 8
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 239000002562 thickening agent Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 7
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 6
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 229920001059 synthetic polymer Polymers 0.000 description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 230000035597 cooling sensation Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229960004793 sucrose Drugs 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 239000001856 Ethyl cellulose Substances 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 4
- UWIULCYKVGIOPW-UHFFFAOYSA-N Glycolone Natural products CCOC1=C(CC=CC)C(=O)N(C)c2c(O)cccc12 UWIULCYKVGIOPW-UHFFFAOYSA-N 0.000 description 4
- 208000004210 Pressure Ulcer Diseases 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 235000019325 ethyl cellulose Nutrition 0.000 description 4
- 229920001249 ethyl cellulose Polymers 0.000 description 4
- 201000005884 exanthem Diseases 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000001341 hydroxy propyl starch Substances 0.000 description 4
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- 206010011985 Decubitus ulcer Diseases 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920001615 Tragacanth Polymers 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 229950008138 carmellose Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229940100486 rice starch Drugs 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 206010016936 Folliculitis Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 206010021531 Impetigo Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000001126 Keratosis Diseases 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 208000006311 Pyoderma Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 235000010407 ammonium alginate Nutrition 0.000 description 2
- 239000000728 ammonium alginate Substances 0.000 description 2
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000305 astragalus gummifer gum Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000007908 dry granulation Methods 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 206010021198 ichthyosis Diseases 0.000 description 2
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical group C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 2
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 239000008239 natural water Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- LQPLDXQVILYOOL-UHFFFAOYSA-I pentasodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)CC([O-])=O LQPLDXQVILYOOL-UHFFFAOYSA-I 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000010408 potassium alginate Nutrition 0.000 description 2
- 239000000737 potassium alginate Substances 0.000 description 2
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000000979 retarding effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 2
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- PDAVHEOHZSVBQQ-UHFFFAOYSA-J tetrasodium;2,2-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].OCC(P([O-])([O-])=O)P([O-])([O-])=O PDAVHEOHZSVBQQ-UHFFFAOYSA-J 0.000 description 2
- USIPWJRLUGPSJM-UHFFFAOYSA-K trisodium 2-(2-aminoethylamino)ethanol triacetate Chemical compound [Na+].[Na+].[Na+].CC([O-])=O.CC([O-])=O.CC([O-])=O.NCCNCCO USIPWJRLUGPSJM-UHFFFAOYSA-K 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 229940038773 trisodium citrate Drugs 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 229940100445 wheat starch Drugs 0.000 description 2
- BAERPNBPLZWCES-UHFFFAOYSA-N (2-hydroxy-1-phosphonoethyl)phosphonic acid Chemical compound OCC(P(O)(O)=O)P(O)(O)=O BAERPNBPLZWCES-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 1
- DMQQXDPCRUGSQB-UHFFFAOYSA-N 2-[3-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CCCN(CC(O)=O)CC(O)=O DMQQXDPCRUGSQB-UHFFFAOYSA-N 0.000 description 1
- SZHQPBJEOCHCKM-UHFFFAOYSA-N 2-phosphonobutane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CCC(P(O)(O)=O)(C(O)=O)CC(O)=O SZHQPBJEOCHCKM-UHFFFAOYSA-N 0.000 description 1
- GOLXRNDWAUTYKT-UHFFFAOYSA-N 3-(1H-indol-3-yl)propanoic acid Chemical group C1=CC=C2C(CCC(=O)O)=CNC2=C1 GOLXRNDWAUTYKT-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- RIHRKDVNDFVRGD-UHFFFAOYSA-N CNC.NCCN Chemical compound CNC.NCCN RIHRKDVNDFVRGD-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- SHWNNYZBHZIQQV-UHFFFAOYSA-J EDTA monocalcium diisodium salt Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-J 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- XEUCQOBUZPQUMQ-UHFFFAOYSA-N Glycolone Chemical compound COC1=C(CC=C(C)C)C(=O)NC2=C1C=CC=C2OC XEUCQOBUZPQUMQ-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 208000023178 Musculoskeletal disease Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- JYXGIOKAKDAARW-UHFFFAOYSA-N N-(2-hydroxyethyl)iminodiacetic acid Chemical compound OCCN(CC(O)=O)CC(O)=O JYXGIOKAKDAARW-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 241000101040 Pityriasis Species 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920000142 Sodium polycarboxylate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 208000014151 Stomatognathic disease Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229910052776 Thorium Inorganic materials 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- PDIZYYQQWUOPPK-UHFFFAOYSA-N acetic acid;2-(methylamino)acetic acid Chemical compound CC(O)=O.CC(O)=O.CNCC(O)=O PDIZYYQQWUOPPK-UHFFFAOYSA-N 0.000 description 1
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000001201 calcium disodium ethylene diamine tetra-acetate Substances 0.000 description 1
- 235000011188 calcium disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 229960005168 croscarmellose Drugs 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- QLBHNVFOQLIYTH-UHFFFAOYSA-L dipotassium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [K+].[K+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O QLBHNVFOQLIYTH-UHFFFAOYSA-L 0.000 description 1
- KDQPSPMLNJTZAL-UHFFFAOYSA-L disodium hydrogenphosphate dihydrate Chemical compound O.O.[Na+].[Na+].OP([O-])([O-])=O KDQPSPMLNJTZAL-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 229960004585 etidronic acid Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940042129 topical gel Drugs 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0275—Containing agglomerated particulates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
Definitions
- the present invention relates to a composition for preparing a gel for external use of carbon dioxide for preparing a gel for external use of carbon dioxide which can easily obtain a cosmetic or medical effect by external use of carbon dioxide, and an external use of carbon dioxide obtained therefrom For gel.
- Japanese Patent Application Laid-Open No. 2000-319187 and WO02Z80941 describe that transdermal and transmucosal absorption of carbon dioxide is caused by athlete's foot, insect worm, atopic dermatitis, monetary eczema, xerosis, seborrhea Eczema, measles, prurigo, housewife eczema, acne vulgaris, impetigo, folliculitis, bunches, swelling, cellulitis, pyoderma, psoriasis, ichthyosis, palmar keratosis, lichen, pity Itching due to mucosal diseases or mucosal disorders such as rash, wounds, burns, cracks, erosions, and erythema, pressure sores, wounds, burns, mouth corners Cutaneous mucosal damage such as inflammation, stomatitis, skin ulcers, cracks, erosions, erythema
- the kit of Japanese Patent Application Laid-Open No. 2000-319187 uses foamed carbon dioxide, so that even if the resulting composition is applied to the skin and mucous membranes, the efficiency of transdermal and transmucosal absorption is not high. . Therefore, long-term continuous use is required in order to sufficiently obtain the cosmetic or medical effects. Specifically, a thin face requires two weeks to two months of daily use. Moreover, since the carbon dioxide in a bubble form forms a useless cavity in the composition obtained by the kit, the carbon dioxide is not used for transdermal transmucosal absorption. At the same time, there is a disadvantage that the fluidity of the whole becomes high, and it hangs down from the coating surface and stains clothes. Furthermore, since the composition obtained by the kit is a viscous substance, a face wash or the like is required at the time of removal after use, which is not convenient.
- the present invention has been made in view of such circumstances, and has a stronger cosmetic or medical effect, can be obtained in a shorter time, does not sag when applied, and is easily removed after use. It is an object of the present invention to provide a composition for preparing a gel for external use of carbon dioxide for preparing a gel for external use of carbon dioxide, and a gel for external use of carbon dioxide obtained thereby.
- the present inventors have conducted intensive research on a carbon dioxide external preparation that can provide a stronger cosmetic or medical effect.
- gelling is performed using cations released from the carbonate, which is a raw material for generating carbon dioxide, and non-bubble carbon dioxide is transdermally and transmucosally absorbed to provide a stronger cosmetic or medical effect. I wanted to get it.
- carbonates and acids rapidly react to generate carbon dioxide, and the reaction between the cations released from the carbonates and the gelling agent is also rapid. Therefore, the generated carbon dioxide may be bubbled in the gel or dissipated into the air, and depending on the type of raw materials and the mixing ratio, the generation of carbon dioxide may be completed before completion of Gelich.
- the first composition for preparing an external carbon dioxide gel of the present invention is used for preparing a gel for external carbon dioxide in which carbon dioxide is dissolved in a gel in a substantially non-bubble state.
- (B) A viscous material containing calcium carbonate, a gelling agent that gels with calcium ions, and water as essential components.
- the gel in the present invention refers to a gel formed by a polymer or the like swollen by a solvent such as water to form a three-dimensional network structure, and it is difficult to separate a large number of solvent molecules into the network structure. .
- substantially non-bubble state in the present invention means that bubble-like carbon dioxide is visually confirmed. Difficult state.
- the granular material in the present invention means any of solids such as powders, fine granules, granules, and microcapsules, or a mixture of these solids.
- the calcium ion scavenger in the present invention means a calcium ion binding agent capable of controlling the gelling speed and the curing speed of a gelling agent which is gelled by calcium ions.
- the first composition for preparing an external gel for carbon dioxide when the granular material (A) and the viscous material (B) are mixed, the weak acid and the viscous material (B) in the granular material (A) are mixed. ) Reacts with the calcium carbonate to generate carbon dioxide, and calcium ions in the viscous material (B) cause gelation by calcium ions released from the calcium carbonate (B). ) And the gel hardens. At this time, since the calcium ion capturing agent captures calcium ions, rapid gelation is suppressed.
- the calcium ion scavenger in the particulate matter (A) acts to delay the contact between the weak acid and calcium carbonate when the particulate matter (A) and the viscous matter (B) are mixed, so that carbon dioxide is rapidly increased.
- the situation is also suppressed.
- the gel hardens before the carbon dioxide dissolves in a non-bubble state, or bubble-like carbon dioxide remains in the gel due to rapid generation of carbon dioxide, or the generated carbon dioxide Dissipation of carbon into the atmosphere is effectively suppressed. Therefore, it is possible to obtain a gel for external use of carbon dioxide in which carbon dioxide in a substantially non-bubble state is largely dissolved in the gel.
- the transdermal and transmucosal absorption of carbon dioxide is large, so that a stronger cosmetic or medical effect can be obtained effectively.
- it is a gel, it has less skin and mucous membrane strength and does not drip easily. Further, if the mixing ratio of the raw materials is adjusted, the gel hardens after a certain period of time from the preparation, and the skin and mucous membrane force can be easily peeled off.
- the granular material (A) is at least one of disodium ethylenediaminetetraacetate and glycine as a calcium ion scavenger.
- the calcium ions are more effectively trapped, so that the rapid progress of the gelling is more effectively suppressed. So, like this According to the external gel for carbon dioxide obtained by the composition for preparing an external gel for carbon dioxide, a stronger cosmetic or medical effect can be obtained more effectively.
- the weak acid of the granular material (A) is at least one of sodium dihydrogen phosphate and potassium dihydrogen phosphate
- the calcium ion scavenger power of the substance (A) is at least one of ethylenediaminetetraacetate sodium and glycine, and is a sodium alginate which is gelled by the calcium ions of the viscous substance (B). Is preferred. In this case, there is an advantage that it is easy to prepare an external carbon dioxide gel in which carbon dioxide in a substantially non-bubble state is dissolved.
- the end time of the generation and dissolution of carbon dioxide is almost the same as the end time of the reaction of the gelling agent, and there is an advantage that a gel for external use of carbon dioxide can be obtained which can more effectively obtain a stronger cosmetic or medical effect. .
- a gel for external use of carbon dioxide that is resistant to dripping of the skin and mucous membranes can be easily obtained, and by adjusting the mixing ratio of raw materials, etc., it is possible to easily obtain a gel for external use that hardens in a certain period of time after preparation and is easy to remove and remove. It has the advantage of being able to.
- the particulate matter (A) further contains a dispersant.
- the granular material (A) when the granular material (A) is dissolved in the viscous material (B), contact between the weak acid and calcium carbonate is suppressed, so that the generation rate of carbon dioxide can be further suppressed. For this reason, the generated carbon dioxide does not bubble into the gel or dissipate into the atmosphere, and immediately dissolves in the gel substantially without bubbles.
- the rate of release of calcium ions released from calcium carbonate is also suppressed, so that the gelling agent gels and cures at an appropriate speed.
- the particulate matter (A) preferably further contains a dispersant and a binder.
- the disintegration control of the granular material (A) is performed more favorably, and the dissolution rate of the granular material (A) is moderate. It becomes. Therefore, according to the external carbon dioxide gel obtained from such a composition for preparing an external carbon dioxide gel, a stronger cosmetic or medical effect can be more effectively obtained.
- the viscous substance (B) further contains an adhesive for increasing the affinity with the skin and mucous membrane surface.
- the mixture of the granular material (A) and the viscous material (B) is further intimately adhered to the skin and mucous membrane, and is less likely to hang down, so that transdermal and transmucosal absorption of carbon dioxide is performed more efficiently.
- the viscous substance (B) preferably further contains an alcohol.
- the elongation of the viscous material (B) is improved and the usability is also improved.
- the average particle diameter of the particulate matter (A) is set in the range of 0.05 to Omm.
- the dissolution speed of the granular material (A) becomes appropriate, and the generation time of carbon dioxide, the ending time of the dissolution and the gelation The end time of the reaction of the agent becomes even more similar.
- the second composition for preparing a gel for external use of carbon dioxide of the present invention is used for preparing a gel for external use of carbon dioxide in which carbon dioxide is dissolved in a gel in a substantially non-bubble state.
- (X) a viscous material (Y) mixed with the granular material (X), and a force.
- (Y) A viscous material containing calcium carbonate, a gelling agent for gelling with calcium ions, a calcium ion scavenger, and water as essential components.
- the dispersant referred to in the present invention is to disperse a raw material such as a weak acid in the granular material to appropriately delay the release of the weak acid in the granular material, and to disperse itself in water at an appropriate speed. Melting or swelling Means to moisturize.
- the granular material (X) and the viscous material (Y) are mixed as in the first composition for preparing an external carbon dioxide gel.
- the weak acid in the particulate matter (X) reacts with the calcium carbonate in the viscous substance (Y) to generate carbon dioxide, and the calcium ions released from the calcium carbonate cause a reaction in the viscous substance (Y).
- the gelling agent gels and the gel hardens.
- the weak acid in the granular material (X) dissolved by the viscous material (Y) is brought into contact with the calcium carbonate by the dispersing agent, so that the generation of carbon dioxide is slowed. Since the ions are captured, the rapid progress of gelling is suppressed.
- a carbon dioxide external gel in which a large amount of substantially non-bubble carbon dioxide is dissolved can be obtained.
- a gel for external use of carbon dioxide since a large amount of carbon dioxide is absorbed percutaneously and transmucosally, a stronger cosmetic or medical effect can be obtained in a shorter time.
- the skin mucous membrane force does not easily sag. Further, if the mixing ratio of the raw materials is adjusted, the gel hardens after a certain period of time from the preparation, and the skin and mucous membrane force can be easily peeled off.
- the granular substance (X) is preferably a calcium ion scavenger, which is disodium hydrogen phosphate.
- the external carbon dioxide gel obtained from such a composition for preparing an external carbon dioxide gel it is possible to more effectively obtain a stronger cosmetic or medical effect.
- the weak acid of the particulate matter (X) is at least one of sodium dihydrogen phosphate and potassium dihydrogen phosphate
- the alginate is sodium alginate
- the calcium ion scavenger of the viscous substance (Y) is sodium hydrogen phosphate.
- the granular material (X) further contains a binder.
- the granular material (X) and the viscous material (Y) are mixed, the granular material (X) is more appropriately controlled for disintegration by being used together with the dispersant in the granular material (X).
- the dissolution rate of the particulate matter (X) becomes appropriate. Therefore, according to the external carbon dioxide gel obtained from such a composition for preparing an external carbon dioxide gel, a stronger cosmetic or medical effect can be more effectively obtained.
- the viscous substance (Y) further contains a pressure-sensitive adhesive for increasing the affinity with the skin and mucous membrane surface.
- the mixture of the granular material (X) and the viscous material (Y) is more intimately adhered to the skin and mucous membrane and is less likely to hang down, and the percutaneous transmucosal absorption of substantially non-bubble carbon dioxide is achieved. It has the advantage of being performed more efficiently.
- the viscous substance (Y) further contains an alcohol.
- the elongation of the viscous material (Y) is improved and the usability is also improved.
- the average particle size of the particulate matter (X) is set in a range of 0.05 to 0.1 mm. ,.
- the dissolution rate of the granular material (X) becomes appropriate, and carbon dioxide is generated.
- the end time of the reaction is even more comparable.
- the external carbon dioxide gel of the present invention comprises the first and second carbon dioxide external gel preparation compositions described above, wherein carbon dioxide is dissolved in the gel in a substantially non-bubble state. It is characterized by According to the above configuration, since the first and second compositions for preparing an external gel for carbon dioxide, which can control the rate of dissolution of carbon dioxide and the rate of reaction of the gelling agent, are substantially used, The gel contains a large amount of carbon dioxide in a non-bubble state. this Therefore, a greater amount of carbon dioxide absorbed transdermally and transmucosally can provide a stronger cosmetic or medical effect.
- the external carbon dioxide gel of the present invention has a lower physical volume at the same weight content of carbon dioxide as compared to a carbon dioxide external preparation of the same weight containing cellular carbon dioxide as an essential component. High strength. Therefore, it has the advantage that it can be applied to the skin and mucous membranes in a thin and uniform thickness, and a strong cosmetic or medical effect can be obtained with a small amount.
- the external carbon dioxide gel of the present invention has an appropriate viscosity and tackiness and does not drip easily from the application surface, so that a strong cosmetic or medical effect can be obtained without soiling clothes and the like. Furthermore, if the mixing ratio of the raw materials is adjusted, the gel hardens after a certain period of time from the preparation, and can be easily separated and removed from the skin and mucous membranes.
- the wound dressing of the present invention uses the first and second compositions for preparing a gel for external use of carbon dioxide, wherein carbon dioxide is dissolved in the gel in a substantially non-bubble state. It is characterized by According to the above configuration, the first and second compositions for preparing a gel for external use of carbon dioxide, which can control the rate of dissolution of carbon dioxide and the rate of reaction of the gelling agent, are substantially used.
- the gel contains a large amount of carbon dioxide in a non-bubble state. Therefore, the greater the amount of carbon dioxide absorbed transdermally and transmucosally, the stronger the healing effect of wounds and the like due to transdermal transmucosal absorption of carbon dioxide can be obtained.
- the gel after applying the gel for external use of carbon dioxide obtained by the first and second compositions for preparing external carbon dioxide gel to a wound or the like and subjecting it to hydrogel sheeting, the gel can be directly adhered to the skin and mucous membrane without being removed immediately.
- This has the advantage that it can function as a protective sheet for wounds and the like.
- the present invention will be described by dividing it into two parts, a first composition for preparing an external gel for carbon dioxide and a second composition for preparing a gel for external carbon dioxide.
- the first composition for preparing a gel for external carbon dioxide comprises a granular material (A) containing a weak acid and a calcium ion scavenger as essential components, and a gelling agent that gels with calcium carbonate and calcium ions. And a viscous substance (B) containing water as an essential component.
- the weak acid constituting the granular material (A) usually refers to a solution in which the pH of a 1% by weight aqueous solution is in the range of 3.0 or more and less than 7.0, and both the inorganic acid and the organic acid alone Or two or more Can be used.
- the reason for using a weak acid is that when a strong acid is used, even if the amount of the strong acid is reduced, the reaction with calcium carbonate is too fast and carbon dioxide is rapidly generated locally, and the generated carbon dioxide is This is because they become bubbles in the gel or dissipate in the atmosphere.
- the weak acid is used to dissolve a large amount of substantially non-bubble carbon dioxide in the gel.
- a weak acid which has a buffering action and does not have an acidity exceeding a certain level even at a high concentration is preferable. More preferably, they are sodium dihydrogen phosphate and potassium dihydrogen phosphate.
- the amount of the weak acid to be blended is generally 575% by weight, more preferably 3050% by weight, based on the total amount of the granular material (A), depending on the type of the weak acid. If the amount is less than 5% by weight, it depends on the amount of the viscous substance (B) used relative to the granular substance (A), the composition of the viscous substance (B), the mixing ratio, and the like. This is because the amount of carbon dioxide in a non-bubble state dissolved in the gel may be too small, or gelation may be insufficient, because the amount is small.
- the amount of generated carbon dioxide and calcium ion generally depend on the amount of the viscous substance (B) used relative to the granular substance (A), the composition of the viscous substance (B), and the mixing ratio. This is because the amount of carbon dioxide released is so large that carbon dioxide may be bubbled in the gel, or the gel may harden quickly and the generation of carbon dioxide may stop. That is, the amount of the weak acid is preferably set within the above range because a large amount of non-bubble carbon dioxide can be dissolved in the gel.
- the calcium ion scavenger constituting the granular material (A) can be used without any particular limitation as long as it binds calcium ions competitively with the gelling agent. Specifically, disodium hydrogen phosphate, sodium polyphosphate, sodium hexametaphosphate, tetrasodium pyrophosphate, sodium tripolyphosphate, hydroxyethanediphosphonic acid, hydroxyethylidenediphosphonic acid, tetrasodium hydroxyethylidenediphosphonate Or phosphonic acid-based calcium ion scavengers such as succinyl, ditrilotris (methylene phosphonic acid) and phosphonobutane tricarboxylic acid, and carboxylic acid-based calcium salts such as trisodium citrate and sodium dalconate Peptide ion scavengers, ethylenediaminetetraacetic acid, disodium ethylenediaminetetraacetate, tris
- ⁇ catching amino acid type calcium ion glycine and the like. These can be used alone or in combination of two or more. Of these, disodium ethylenediaminetetraacetate and glycine are preferred because they are excellent in controlling the capture and re-release of calcium ions and in controlling the gelation rate and curing rate.
- the compounding amount of the calcium ion scavenger is preferably 0.5 to 50% by weight based on the force S depending on the type of the calcium ion scavenger, and the total amount of the particulate matter (A). 0 to 40% by weight is more preferable. If the content is less than 0.5% by weight, depending on the amount of the viscous substance (B) used relative to the granular substance (A), the compounding components of the viscous substance (B), and the mixing ratio, etc., insufficient capture of calcium ions may occur. This is because gelation and gel hardening proceed rapidly, and carbon dioxide generation may stop.
- Granules (A) containing a weak acid and a calcium ion scavenger as essential components are, for example, fine granules or condyles, and have an average particle size (half of the sum of the maximum length and the minimum length in one piece). Is preferably set in the range of 0.05 to 1. Omm, particularly preferably in the range of 0.1 to 0.3 mm. That is, it is preferable that the particle size is smaller than the granular material of the conventional composition for preparing a carbon dioxide external preparation (see WO02 / 80941).
- the granular material (A) is too large, it will take a time force S to dissolve when mixed with the viscous material (B) and the reaction between the weak acid and calcium carbonate will occur. This is because the reaction tends to be difficult to proceed, and as a result, the generation of carbon dioxide may be too slow, and gelation and gel hardening may not be sufficiently performed. Conversely, if the particulate matter (A) is too small, when mixed with the viscous substance (B), the particulate matter (A) will dissolve immediately, and the reaction between the weak acid and calcium carbonate tends to proceed too quickly.
- the surface of the granular material (A) has more irregularities than the mirror surface because more uniform disintegration and dissolution occur due to contact with the viscous material (B).
- the granular material (A) may contain, as necessary, a dispersing agent used for preventing the reaction between the weak acid and calcium carbonate from being performed too quickly, and a method for maintaining the shape of the particles. It can be produced by employing a known production method such as a wet granulation method or a dry granulation method using a material to which a binder or the like used for this purpose is added.
- the dispersing agent can be used without any particular limitation as long as it is a fine particle, which can be relatively dissolved or swelled when mixed with the viscous substance (B) or can disperse other raw materials immediately.
- starch derivatives such as alpha-monostarch and ⁇ -cyclodextrin; sugars such as sucrose, glucose, fructose, sucrose, lactose, xylitol, D-sorbitol, and D-mannitol; polysaccharides such as punorelane and xanthan gum; Cellulose derivatives such as hydroxypropylcellulose, hydroxypropynolemethinoresenorelose, canolemelose kanoresime, sodium noremelose sodium and their salts, synthetic polymers such as polybierpyrrolidone, and urea can be used. . These are used alone or in combination of two or more
- the binder is a fine particle which is used by being dissolved or swelled in an appropriate solvent, and may be used without any particular limitation as long as it can bind two or more substances.
- the weak acid and the calcium ion scavenger are preferably dispersed as uniformly as possible.
- the calcium ion concentration is prevented from locally increasing or decreasing, and the amount of carbon dioxide generated is also reduced locally. This is because too many or too few are suppressed. That is, a carbon dioxide external gel in which a sufficient amount of carbon dioxide is dissolved in a non-bubble state in the entire gel can be obtained.
- the surface of the granular material (A) may be treated with a retarding material (the dissolution rate with respect to the viscous material (B)).
- a retarding material the dissolution rate with respect to the viscous material (B)
- a raw material that delays the release of weak acid by controlling the release of weak acids, etc., or using a binder in the production of the granular material (A) to delay the disintegration rate of the granular material (A)
- the disintegration rate control type granular material as described above may be used.
- the viscous substance (B) used together with the above-mentioned granular substance (A) contains calcium carbonate as an essential component.
- the reason for using calcium carbonate as the carbonate is as follows. That is, when carbonic acid, which is a carbonate containing the same divalent metal ion as calcium carbonate, is used, carbon dioxide is naturally generated by the reaction with an acid. In such a case, the hardness of the gel tends to decrease. As a result, the carbon dioxide generated in the gel is easily bubbled or dissipated into the atmosphere, so that a substantially non-bubble carbon dioxide sufficiently dissolved external carbon dioxide gel is obtained. Is difficult. As such, calcium carbonate is used as an essential component as a raw material for generating carbon dioxide and releasing divalent metal ions.
- the compounding amount of calcium carbonate is preferably 0.16.0% by weight based on the force S depending on the type and amount of the weak acid or gelling agent, and generally on the total amount of the viscous substance (B).
- the content is more preferably 0.2 to 2.0% by weight, and even more preferably 0.3 to 1.0% by weight. If the content is less than 0.1% by weight, the amount of the granular material (A) to be used with respect to the viscous material (B), the compounding components of the granular material (A), and the mixing ratio This is because the amount of carbon dioxide generated may be too small or Gerich may be insufficient.
- the granular material (A) may be reduced depending on the amount of the granular material (A) used with respect to the viscous material (B), the composition of the granular material (A), and the mixing ratio.
- the rate of carbon dioxide generation and dissolution is too high, and the generated carbon dioxide may be bubbled in the gel or dissipated into the atmosphere.
- the gelling agent constituting the viscous substance (B) can be used without any particular limitation as long as it can gelate with calcium ions released from calcium carbonate.
- the gelling agent constituting the viscous substance (B) can be used without any particular limitation as long as it can gelate with calcium ions released from calcium carbonate.
- larginan, low methoxylated pectin, sodium alginate, potassium alginate, ammonium alginate and the like can be used. These may be used alone or in combination of two or more. Among them, sodium alginate is preferred because of its excellent affinity with the skin and mucous membranes and good feeling in use.
- the amount of the gelling agent is preferably 0.3 to 15.0% by weight, more preferably 0.3% to 15.0% by weight based on the total amount of the viscous substance (B), depending on the type of the gelling agent and the like. It is 0.3-8.0% by weight, more preferably 1.5-5.0% by weight.
- the amount is less than 0.3% by weight, the granular material (A) is mixed with the viscous material (B) depending on the amount of the granular material (A) used, the compounding component of the granular material (A), and the mixing ratio. This is because the gelling of the viscous substance (B) sometimes becomes insufficient, and the generated carbon dioxide may be bubbled or diffused into the atmosphere.
- water constituting the viscous substance (B) natural water, tap water, distilled water, purified water and the like are used without any particular limitation.
- Carbon dioxide dissolves not only in water but also in many other solvents including organic solvents and lipids.In particular, water reacts with calcium carbonate as soon as a weak acid reacts with organic solvents and lipids. The generation and dissolution of carbon dioxide, the release of calcium ions, and the gelling of gelling agents can easily occur. Water is generally easy to handle, cheap and safe. Such power, water, and water are used as essential components.
- the amount of water is generally determined by the type and amount of other raw materials. 70-95% by weight based on the total amount of the viscous substance (B) is preferred. If the content is less than 70% by weight, the reaction between the weak acid and the calcium carbonate, which is difficult to dissolve the particulate matter (A), may occur. Conversely, if the content exceeds 95% by weight, the amount of other essential components is too small, and when the particulate matter (A) is mixed, the curing of the geli-dani gel becomes insufficient or the amount of generated carbon dioxide is reduced. This is because there is a possibility that the result will be insufficient.
- the viscous substance (B) containing calcium carbonate, a gelling agent and water as essential components is such that when mixed with the granular substance (A), the granular substance (A) spreads and is easily and uniformly dispersed. It is preferable that the resin has a viscosity such that the viscosity can be reduced. If the granular material (A) is mixed directly with the viscous material (B) and immediately applied directly to the skin and mucous membranes, use it immediately after mixing to prevent dripping from the skin and mucous membranes. It is better to have it.
- the viscous substance (B) is mixed with the above-mentioned essential component, if necessary, by adding an adhesive (hereinafter also referred to simply as "adhesive") for enhancing the affinity with the skin and mucous membrane surface. By doing so, it can be manufactured.
- an adhesive hereinafter also referred to simply as "adhesive”
- Examples of the adhesive include gum arabic, crystalline cellulose, sodium carmellose, methinoresenorelose, hydroxypropinoresenololose, hydroxypropinolemethinoresenorelose, hydroxypropylmethylcellulose terephthalate, carboxymethylcellulose sodium, carboxymethylethyl.
- the blending amount of the pressure-sensitive adhesive depends on the type of the pressure-sensitive adhesive and the like, but is preferably about 0.1 to 5.0% by weight based on the total amount of the viscous substance (B). If the amount is less than 0.1% by weight, the adhesive strength is insufficient and there is not much meaning in blending. Conversely, if it exceeds 5.0% by weight, the adhesive strength is so strong that removal from the skin and mucous membrane after use may be difficult.
- the first composition for preparing a gel for external use of carbon dioxide comprising the above-mentioned granular material (A) and viscous material (B) can be used, for example, as follows. That is, first, the granular material (A) and the viscous material (B) are mixed at a predetermined ratio in various containers. The ratio of both is calcium carbonate. It is preferred that the system be set up so that it reacts with all the weak acids. However, the reaction between calcium carbonate and the weak acid is too fast, and gelation and gel hardening proceed rapidly, or carbon dioxide is generated too quickly, causing carbon dioxide to bubble in the gel or dissipate in the atmosphere.
- the molar ratio of the weak acid of the granular material (A) to the calcium carbonate of the viscous material (B) is about 0.4 to 40 when 0.1% by weight of calcium carbonate is blended. In the case of 0.3% by weight of calcium carbonate, about 0.04 to 3.6 is preferable, and in the case of 6.0% by weight of calcium carbonate, about 0.02 to 0.54 is preferable. . Subsequently, the resulting mixture is immediately applied to a predetermined site of the skin mucosa.
- a gel for external use of carbon dioxide in which carbon dioxide generated by the reaction between the weak acid and calcium carbonate is dissolved in a substantially non-bubble state in the gel is obtained, and the carbon dioxide is transdermally and transmucosally absorbed into the skin and mucous membranes.
- a strong beauty or medical effect can be obtained.
- the gel hardens after a certain period of time from the preparation, so that the gel can be easily peeled off from the skin and mucous membrane.
- At least one of the granular material (A) and the viscous material (B) may be added to raw materials ordinarily used in external preparations or cosmetics, for example, fragrances, pigments, or the like, within a range not to impair the effects of the present invention.
- Surfactants, oils, humectants, thickeners, alcohols, preservatives, antioxidants, anti-coloring agents, ultraviolet absorbing and scattering agents, chemicals, and the like may be added as necessary.
- the obtained gel for external use of carbon dioxide can be more suitably used as a cosmetic or an external medicine.
- alcohols for the viscous substance (B) because the elongation of the gel is improved and the usability is improved.
- a thickener for at least one of the granular material (A) and the viscous material (B) for the purpose of improving the viscosity and tackiness of the gel.
- Examples of the alcohols include monohydric alcohols such as ethanol, propanol, isopropanol, and butanol, 1,3-butylene glycol, xylitol, glycerol, sonorebitone, propylene glycolone, dipropylene glycolone, and hexylene glycol.
- Monohydric alcohols such as ethanol, propanol, isopropanol, and butanol, 1,3-butylene glycol, xylitol, glycerol, sonorebitone, propylene glycolone, dipropylene glycolone, and hexylene glycol.
- Polyhydric alcohols such as glue, ethylene glycol and polyethylene glycol can be used. These can be used alone or in combination of two or more. Among them, 1,3-butylene glycolone, propylene glycolone-pentylene glycolone, glycerone, Polyethylene glycol is preferred.
- a natural polymer a semi-synthetic polymer, a synthetic polymer, or an inorganic material as described below can be used. These can be used alone or in combination of two or more.
- Natural polymers plant polymers such as gum arabic, galactan, agar, quince seed gum, guar gum, tragacanth gum, pectin, mannan, locust bean gum, rice starch, flour starch, corn starch, potato starch, and curd Microbial polymers such as orchid, xanthan gum, succinognolecan, dextran, hyanoreonic acid, and pullulan; and protein-based polymers such as anolebumin, casein, collagen, gelatin, and fibrin.
- plant polymers such as gum arabic, galactan, agar, quince seed gum, guar gum, tragacanth gum, pectin, mannan, locust bean gum, rice starch, flour starch, corn starch, potato starch, and curd
- Microbial polymers such as orchid, xanthan gum, succinognolecan, dextran, hyanoreonic acid, and pullulan
- protein-based polymers such as an
- Semi-synthetic polymer ethyl cellulose, processed starch, carboxymethyl cellulose and its salts, carboxymethyl ethyl cellulose and its salts, carboxymethyl starch and its salts, croscarmellose and its salts, crystalline cellulose, acetic acid Cellulose, Senorelose acetate phthalate, Hydroxyethylsenorellose, Hydroxypropyl starch, Hydroxypropylcellulose, Hydroxypropylmethylcellulose, Hydroxyl pinolemethinoresenololose phthalate, Powdered cenorelose, Methylsenorelose, Methynoreoxypropylcellulose, etc.
- Cellulose-based polymers such as pre-alpha starch, partially alpha-modified starch, carboxymethyl starch, dextrin and methyl starch, chondroitin sulfate Thorium, other polysaccharide polymers such as sodium hyaluronate.
- Synthetic polymer carboxyvinyl polymer, sodium polyacrylate, polyvinylaceta-l-ethylacetylaminoacetate, polyvinyl alcohol, polybutylpyrrolidone, methacrylic acid-ethyl acrylate copolymer, methacrylic acid-methacrylic Ethyl acrylate copolymer, ethyl methacrylate 'trimethylammonium methacrylate methacrylate copolymer, dimethylaminoethyl methacrylate' methyl methacrylate copolymer, and the like.
- Inorganic substances hydrous silicon dioxide, light silicic anhydride, colloidal alumina, bentonite, laponite, etc.
- the granular substance (A) and the viscous substance (B) are stored in a state in which they do not substantially come into contact with each other until they are used. Preferably, it is stored in a closed state.
- the storage container can be used without any particular limitation on the material, shape, structure, etc. Examples of the material include plastic, glass, aluminum, paper, various polymers, and composites of these materials. Examples include cups, tubes, bags, bottles, sticks, and pumps, and any of these can be used without particular limitation.
- the second composition for preparing an external gel for carbon dioxide comprises a granular material (X) containing a weak acid and a dispersant as essential components, a gelling agent gelled by calcium carbonate and calcium ions, and calcium. It acts as a viscous substance (Y) containing an ion scavenger and water as essential components. That is, compared with the first composition for preparing a gel for external use of carbon dioxide, the calcium ion scavenger is used as an essential component in the viscous substance (Y) instead of the granular substance (X), and the granular substance (X) is used. The difference is that a dispersant is used as an essential component.
- the weak acid constituting the particulate matter (X) is, as in the first composition for preparing an external gel for carbon dioxide, usually a 1% by weight aqueous solution having a pH in the range of 3.0 or more and less than 7.0. Any of inorganic acids and organic acids can be used alone or in combination of two or more. The reason for using a weak acid is the same as in the first composition for preparing a gel for external use of carbon dioxide. Among the weak acids, those that have a buffering effect and do not have a certain level of acidity even at a high concentration are preferred. More preferred are sodium dihydrogen phosphate and potassium dihydrogen phosphate.
- the compounding amount of the weak acid is preferably 1075% by weight, more preferably 1060% by weight, and still more preferably 20% by weight, based on the total amount of the granular material (X). — 50% by weight. That is, it is preferable that the amount is slightly smaller than the first composition for preparing a gel for external use of carbon dioxide. Here, the above range is preferable.
- the force generally depends on the amount of the viscous substance (Y) used relative to the granular substance (X), the composition of the viscous substance (Y), the composition ratio, and the like.
- the dispersant constituting the granular material (X) is a fine particle, as long as it can disperse other raw materials relatively easily when dissolved and swollen when mixed with the viscous material (Y). It can be used without particular limitation.
- the reason why the dispersant is an essential component in the granular material (X) is that when the granular material (X) is dissolved in the viscous material (Y), the dispersing agent in the granular material (X) containing no calcium ion trapping agent is used. This is to prevent early contact between the weak acid and the calcium carbonate in the viscous substance (Y).
- dispersants examples include starch derivatives such as alpha-starch and para-cyclodextrin, sucrose, glucose, fructose, sucrose, lactose, xylitole, sugars such as D-sonorebitonere, D-mannitol, pullulan, xanthanga
- starch derivatives such as alpha-starch and para-cyclodextrin
- sucrose glucose, fructose, sucrose, lactose, xylitole
- sugars such as D-sonorebitonere, D-mannitol, pullulan
- xanthanga Polysaccharides such as cellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, cellulose derivatives such as carmellose calcium and carmellose sodium and salts thereof
- synthetic polymers such as polyvinylpyrrolidone, and urea can be used. These may be used alone or in combination of two or more.
- the amount of the dispersant depends on the type and amount of the weak acid, but is generally from 10 to 90% by weight, preferably from 20 to 40% by weight, based on the total amount of the particulate matter (X). More preferred. If the amount is less than 10% by weight, depending on the amount of the viscous substance (Y) used relative to the granular substance (X), the composition of the viscous substance (Y), the mixing ratio, etc., when mixed with the viscous substance (Y), a weak acid If the local concentration of is too high, the reaction with calcium carbonate may occur rapidly in one part of the viscous substance (Y) and end, and the whole may not be gelled.
- the viscous substance (Y) is mixed with the viscous substance (Y), depending on the amount of the viscous substance (Y) used relative to the granular substance (X), the compounding components of the viscous substance (Y), and the mixing ratio.
- the local concentration of the weak acid is too low, The amount of carbon dioxide generated and the amount of released calcium ions are insufficient, so a sufficient amount of carbon dioxide does not dissolve in a non-bubble state, or the carbon dioxide generated due to insufficient gelation is bubbled. Or it may be dissipated into the atmosphere.
- Granules (X) containing a weak acid and a dispersant as essential components are, for example, fine granules or granules, and have an average particle size (half of the maximum length and the minimum length in one piece) of approximately 0. 05-1. Omm is preferable, and particularly preferably 0.1-0.3 mm. That is, it is preferable that the particle size be smaller than the conventional granular material (see WO02 / 80941) of the composition for preparing a carbon dioxide external preparation.
- particulate matter (X) If the particulate matter (X) is too large, it takes a long time to dissolve when mixed with the viscous matter (Y), and the reaction between the weak acid and calcium carbonate tends to be difficult to progress, and as a result, This is because the generation of carbon dioxide may be too slow or gelation and gel hardening may not be sufficiently performed. Conversely, if the particulate matter (X) is too small, when mixed with the viscous matter (Y), the particulate matter (X) will dissolve immediately and the reaction between the weak acid and calcium carbonate tends to proceed too quickly.
- the surface of the granular material (X) has more irregularities than the mirror surface because more uniform disintegration and dissolution occur by contact with the viscous material (Y).
- the granular material (X) is obtained by adding a binder used for maintaining the shape of the particles, etc., to the essential components, if necessary, using a wet granulation method or a dry granulation method. It can be produced by employing a known production method such as a granulation method.
- a binder those similar to the first composition for preparing a gel for external use of carbon dioxide can be used.
- the weak acid and the dispersant are preferably dispersed as uniformly as possible.
- the calcium ion concentration is prevented from locally increasing or decreasing, and the amount of carbon dioxide generated is also reduced locally. This is because too many or too few are suppressed. That is, a carbon dioxide external gel in which a sufficient amount of carbon dioxide is dissolved in a non-bubble state in the entire gel can be obtained.
- the surface of the granular material (X) may be coated with a retarding material (the dissolution rate with respect to the viscous material (Y)).
- a retarding material the dissolution rate with respect to the viscous material (Y)
- Controlled release type granules that control the release of weak acids, etc. by coating with a raw material), or use a binder in the production of the granules (X) to delay the disintegration rate of the granules (X)
- the disintegration rate control type granular material as described above may be used.
- the viscous substance (Y) used together with the above-mentioned granular substance (X) has calcium carbonate as an essential component.
- the reason for using calcium carbonate as the carbonate is the same as in the first composition for preparing an external carbon dioxide gel.
- the amount of calcium carbonate depends on the type and amount of the weak acid or gelling agent, but is generally 0.16.0% by weight based on the total amount of the viscous substance (Y). Preferably it is 0.2-2.0% by weight, more preferably 0.3-1.0% by weight.
- the amount of carbon dioxide generated is small, depending on the amount of the granular material (X) used in the viscous material (Y), the composition of the granular material (X), and the blending ratio. This is because there is a risk that the film breaks or the gelling becomes insufficient. Conversely, if the content exceeds 6.0% by weight, the granular material (X) is reduced depending on the amount of the granular material (X) used relative to the viscous material (Y), the compounding components of the granular material (X), and the mixing ratio. This is because the generation and dissolution rate of carbon dioxide is too fast when mixed, and the generated carbon dioxide may be bubbled in the gel or dissipated into the atmosphere.
- the gelling agent constituting the viscous substance (Y) is not particularly limited as long as it gels with calcium ions released from calcium carbonate, similarly to the first composition for preparing an external carbon dioxide gel. It can be used without.
- carrageenan low-methoxy-loud dang vector
- sodium alginate potassium alginate
- ammonium alginate and the like. These may be used alone or in combination of two or more. Among them, sodium alginate is preferred because of its excellent affinity with the skin mucous membrane and good feeling of use.
- the amount of the gelling agent to be blended is preferably 0.315.0% by weight, more preferably 0.3% by weight, based on the total amount of the viscous substance (Y), depending on the type of gelling agent and the like. 3 to 8.0% by weight, more preferably 1.5 to 5.0% by weight. If the amount is less than 0.3% by weight, it depends on the amount of the granular material (X) used with respect to the viscous material (Y), the composition of the granular material (X), and the mixing ratio. This is because, when the substance (X) is mixed, the gelling of the viscous substance (Y) becomes insufficient, and the generated carbon dioxide may be bubbled or diffused into the atmosphere.
- the granular material (X) is reduced depending on the amount of the granular material (X) used relative to the viscous material (Y), the compounding components of the granular material (X), and the mixing ratio. This is because when mixed, the viscosity of the viscous substance (Y) becomes so high that it is difficult to further dissolve the granular substance (X), and the reaction between the weak acid and calcium carbonate may not easily occur.
- the calcium ion scavenger composing the viscous substance (Y) an alkaline or neutral substance that competitively binds calcium ions to the gelling agent is used.
- the particulate matter (A) contains a calcium ion scavenger, so even if it is acidic, it reacts with calcium carbonate during storage to generate carbon dioxide. I will not.
- a calcium ion scavenger is contained in the viscous substance (Y), so if the substance is acidic, it reacts with carbonic acid during the preparation of the viscous substance (Y) to generate carbon dioxide.
- a calcium ion scavenger that not only binds calcium ions competitively with the gelling agent but also is alkaline or neutral is used.
- Preferred is disodium hydrogen phosphate.
- the amount of the calcium ion trapping agent depends on the type of the calcium ion trapping agent, but is preferably about 0.1 to 1.0% by weight based on the total amount of the viscous substance (Y). If the content is less than 0.1% by weight, the force due to the amount of the granular material (X) used relative to the viscous material (Y), the composition of the granular material (X), the blending ratio, etc. Insufficient capture of calcium ions This is because the gelation and the hardening of the gel proceed rapidly, and the generation of carbon dioxide may stop.
- water constituting the viscous substance (Y) natural water, tap water, distilled water, purified water and the like are used without any particular limitation. Water is an essential component for the same reason as in the first composition for preparing a gel for external use of carbon dioxide.
- the amount of water is preferably 70 to 95% by weight based on the total amount of the viscous substance (Y) depending on the type and amount of other raw materials. If the content is less than 70% by weight, the reaction between the weak acid and the calcium carbonate, which easily dissolves the particulate matter (X), may possibly occur. Conversely, if the content exceeds 95% by weight, the amount of other essential components is too small, and when the particulate matter (X) is mixed, gelation or gel hardening becomes insufficient, or the amount of carbon dioxide generated is reduced. This is because there is a possibility that the result will be insufficient.
- the viscous substance (Y) can be produced by adding and mixing, as necessary, an adhesive or the like for increasing the affinity with the skin and mucous membrane surface.
- the type and amount of the pressure-sensitive adhesive are the same as those of the first composition for preparing a gel for external use of carbon dioxide.
- the second composition for preparing a gel for external use of carbon dioxide comprising the above-mentioned granular material (X) and viscous material (Y) can be used, for example, as follows. That is, first, the granular substance (X) and the viscous substance (Y) are mixed at a predetermined ratio in various containers. The ratio between the two is preferably set so that calcium carbonate reacts completely with the weak acid. However, the reaction between calcium carbonate and the weak acid is too fast, and gelation and gel hardening proceed rapidly, or carbon dioxide is generated too quickly, causing carbon dioxide to bubble in the gel or dissipate in the atmosphere. It is not preferable to use more granular material (X) than viscous material (Y).
- the molar ratio between the weak acid of the granular material (X) and the calcium carbonate of the viscous material (Y) is In the case of 0.1% by weight of shim, approximately 0.4 to 40 is preferred for calcium carbonate 0.3 In the case of 0.3% by weight, approximately 0.04 to 3.6 is preferred for calcium carbonate 6. In the case of 0% by weight, the content is preferably about 0.02 to 0.54. Subsequently, the resulting mixture is immediately applied to a predetermined site of the skin mucosa.
- a gel for external use of carbon dioxide in which carbon dioxide generated by the reaction between the weak acid and calcium carbonate is dissolved in a substantially non-bubble state in the gel is obtained, and the carbon dioxide is transdermally and transmucosally absorbed into the skin and mucous membranes.
- a strong beauty or medical effect can be obtained.
- the gel hardens after a certain period of time from the preparation, so that the gel can be easily peeled off from the skin and mucous membrane.
- At least one of the granular substance (X) and the viscous substance (Y) may be used as a raw material usually used for an external preparation or a cosmetic, for example, a fragrance, a pigment, or the like, as long as the effects of the present invention are not impaired.
- Surfactants, oils, humectants, thickeners, alcohols, preservatives, antioxidants, anti-coloring agents, ultraviolet absorbing and scattering agents, chemicals, and the like may be added as necessary.
- the obtained gel for external use of carbon dioxide can be more suitably used as an external medicine or cosmetic.
- alcohols for the viscous substance (Y) because the extension of the gel is improved and the usability is improved.
- a thickener for at least one of the granular material (X) and the viscous material (Y) from the viewpoint of improving the viscosity and tackiness of the gel.
- the same alcohols and thickeners as those used in the first carbon dioxide external gel preparation composition are used.
- the granular material (X) and the viscous material (Y) do not substantially come into contact with each other until use, and are stored in a state. It is preferable to store in a sealed state if possible.
- the storage container can be used without any particular limitation on the material, shape, structure, and the like.
- the material include plastic, glass, aluminum, paper, various polymers, and composites of these materials. Examples thereof include cups, tubes, bags, bottles, sticks, and pumps, and any of these can be used without any particular limitation.
- composition for preparing a gel for external use of carbon dioxide of the present invention will be specifically described with reference to examples, but the present invention is not limited to these examples.
- “parts by weight” is abbreviated as “parts”.
- Examples 115 below are examples of the first composition for preparing a gel for external use of carbon dioxide.
- Granules (average particle diameter: 0.3 mm) were prepared with an appropriate amount of water using 65 parts of sodium dihydrogen phosphate as a weak acid and 35 parts of disodium ethylenediaminetetraacetate as a calcium scavenger.
- Examples 6 to 25 below are examples of the first composition for preparing a gel for external use of carbon dioxide, in which sodium dihydrogen phosphate was used as the weak acid of the granular material (A).
- sodium dihydrogen phosphate was used as the weak acid of the granular material (A).
- disodium ethylenediaminetetraacetate was used as a calcium ion scavenger, and the mixing ratio of the two was mainly changed.
- a viscous substance (B) was prepared in the same manner as in Example 6.
- a viscous substance (B) was prepared in the same manner as in Example 6.
- a viscous substance (B) was prepared in the same manner as in Example 6.
- a viscous substance (B) was prepared in the same manner as in Example 10.
- a viscous substance (B) was prepared in the same manner as in Example 10.
- a viscous substance (B) was prepared in the same manner as in Example 10.
- a viscous substance (B) was prepared in the same manner as in Example 10.
- a viscous substance (B) was prepared in the same manner as in Example 10.
- a viscous substance (B) was prepared in the same manner as in Example 10.
- a viscous substance (B) was prepared in the same manner as in Example 10.
- a viscous substance (B) was prepared in the same manner as in Example 10.
- a viscous substance (B) was prepared in the same manner as in Example 19.
- a viscous substance (B) was prepared in the same manner as in Example 19.
- a viscous substance (B) was prepared in the same manner as in Example 22.
- a viscous substance (B) was prepared in the same manner as in Example 22.
- a viscous substance (B) was prepared in the same manner as in Example 22.
- Example 2636 is an example of the first composition for preparing a gel for external use of carbon dioxide, in which sodium dihydrogen phosphate or potassium dihydrogen phosphate is used as the weak acid for the particulate matter (A).
- sodium dihydrogen phosphate or potassium dihydrogen phosphate is used as the weak acid for the particulate matter (A).
- glycine was used as a calcium ion scavenger for the granular material (A), and the mixing ratio of both was mainly changed.
- a viscous substance (B) was prepared in the same manner as in Example 26.
- a viscous substance (B) was prepared in the same manner as in Example 26.
- a viscous substance (B) was prepared in the same manner as in Example 26.
- a viscous substance (B) was prepared in the same manner as in Example 26.
- a viscous substance (B) was prepared in the same manner as in Example 26.
- a viscous substance (B) was prepared in the same manner as in Example 26.
- a viscous substance (B) was prepared in the same manner as in Example 26.
- a viscous substance (B) was prepared in the same manner as in Example 26.
- a viscous substance (B) was prepared in the same manner as in Example 26.
- a viscous substance (B) was prepared in the same manner as in Example 26.
- Example 3740 is an example of the second composition for preparing a gel for external use of carbon dioxide, wherein disodium hydrogen phosphate was used as a calcium ion scavenger for the viscous substance (Y).
- disodium hydrogen phosphate was used as a calcium ion scavenger for the viscous substance (Y).
- sodium dihydrogen phosphate was used as the weak acid of the state (X), and the mixing ratio of the sodium dihydrogen phosphate was variously changed.
- a viscous substance (Y) was prepared using 5 parts, 2.7 parts of pentylene glycol as an alcohol and a preservative.
- a viscous substance ( ⁇ ) was prepared in the same manner as in Example 37.
- a viscous substance (Y) was prepared in the same manner as in Example 37.
- a viscous substance (Y) was prepared in the same manner as in Example 37.
- Examples 41 to 59 below are examples of the first composition for preparing a gel for external use of carbon dioxide, in which a binder is contained in the particulate matter (A), and the type, blending ratio and This is an example of various changes.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- Granules (average particle size: 0.3 mm) were prepared with an appropriate amount of 50% ethanol.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- Granules (average particle size 0.3 mm) were prepared with an appropriate amount of 50% ethanol.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- Granules (average particle size 0.3 mm) were prepared with an appropriate amount of 50% ethanol.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- Granules (average particle size 0.3 mm) were prepared with an appropriate amount of 50% ethanol.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- Granules (average particle size: 0.3 mm) were prepared with an appropriate amount of 50% ethanol.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- Granular granules (average particle size 0.3 mm) were prepared with an appropriate amount of 50% ethanol.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- Granules (average particle size 0.3 mm) were prepared with an appropriate amount of 50% ethanol.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- the composition was prepared.
- Granules (average particle size 0.3 mm) were prepared with an appropriate amount of 50% ethanol.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- a viscous substance (B) was prepared in the same manner as in Example 41.
- Example 6069 is an example of the first composition for preparing a gel for external use of carbon dioxide, in which the granular material (A) contains a dispersant and the type of the dispersant is variously changed. It is. (Example 60)
- a viscous substance (B) was prepared in the same manner as in Example 60.
- a viscous substance (B) was prepared in the same manner as in Example 60.
- a viscous substance (B) was prepared in the same manner as in Example 60.
- a viscous substance (B) was prepared in the same manner as in Example 60.
- a viscous substance (B) was prepared in the same manner as in Example 60.
- a viscous substance (B) was prepared in the same manner as in Example 60.
- a viscous substance (B) was prepared in the same manner as in Example 60.
- a viscous substance (B) was prepared in the same manner as in Example 60.
- a viscous substance (B) was prepared in the same manner as in Example 60.
- Examples 70 to 86 below are examples of the first composition for preparing a gel for external use of carbon dioxide, in which a viscous substance (B) is coated with an adhesive or the like for increasing the affinity with the skin and mucous membrane surface. This is an example in which the composition of the viscous substance (B) is variously changed.
- viscous substance (B) 0.4 parts of calcium carbonate, 3.5 parts of sodium alginate as a gelling agent that gels with calcium ions, 79.0 parts of purified water as water, carboxy as an adhesive to increase affinity with the skin and mucous membrane surface 0.9 parts of sodium methylcellulose, 10.0 parts of 1,3-butylene glycol as alcohols, 0.5 parts of phenoxyethanol as preservative, 5.7 parts of alcohols and pentylene glycol as preservative Then, a viscous substance ( ⁇ ) was prepared.
- a granular material ( ⁇ ) was prepared in the same manner as in Example 70.
- a granular material ( ⁇ ) was prepared in the same manner as in Example 70.
- a granular material (A) was prepared in the same manner as in Example 70.
- a granular material (A) was prepared in the same manner as in Example 70.
- a viscous substance (B) was prepared by using 0.5 parts of phenoxyethanol as a solvent, 2.7 parts of pentylene glycol as an alcohol and a preservative.
- a granular material (A) was prepared in the same manner as in Example 70. (Preparation of viscous substance (B))
- a granular material (A) was prepared in the same manner as in Example 70.
- a granular material (A) was prepared in the same manner as in Example 70.
- a viscous substance ( ⁇ ) was prepared using 6.0 parts of 1,3-butylene glycol, 0.5 parts of phenoxyethanol as a preservative, 2.7 parts of alcohol and pentylene glycol as a preservative.
- a granular material ( ⁇ ) was prepared in the same manner as in Example 70.
- a granular material ( ⁇ ) was prepared in the same manner as in Example 70.
- the composition was prepared.
- a granular material (A) was prepared in the same manner as in Example 70.
- a granular material (A) was prepared in the same manner as in Example 70.
- a viscous substance (B) was prepared by using 0.9 parts of sodium methylcellulose, 6.0 parts of 1,3-butylene glycol as alcohols, and 0.5 part of phenoxyethanol as a preservative.
- a granular material (A) was prepared in the same manner as in Example 70.
- viscous substance (B) 0.4 parts of calcium carbonate, 3.5 parts of sodium alginate as a gelling agent that gels with calcium ions, 88.0 parts of purified water as water, carboxy as an adhesive to increase affinity with the skin and mucosal surfaces 0.9 parts of sodium methylcellulose, 4.0 parts of 1,3-butylene glycol as alcohols, 0.5 parts of phenoxyethanol as preservatives, 2.7 parts of pentylene glycol as alcohols and preservatives Then, a viscous substance ( ⁇ ) was prepared.
- a granular material ( ⁇ ) was prepared in the same manner as in Example 70.
- a viscous substance ( ⁇ ) was prepared by using 0.9 parts of sodium methylcellulose, 0.5 parts of phenoxyethanol as a preservative, 5.7 parts of pentylene glycol as an alcohol and a preservative.
- a granular material ( ⁇ ) was prepared in the same manner as in Example 70.
- a viscous substance ( ⁇ ) was prepared by using 0.9 parts of sodium methylcellulose, 0.5 parts of phenoxyethanol as a preservative, 2.7 parts of pentylene glycol as an alcohol and a preservative. Then, the obtained granular material (A) and viscous material (B) were combined to obtain a carbon dioxide external gel preparation composition.
- a granular material (A) was prepared in the same manner as in Example 70.
- a viscous substance (B) was prepared using 0.9 parts of sodium methylcellulose and 0.5 parts of phenoxyethanol as a preservative.
- a granular material (A) was prepared in the same manner as in Example 70.
- a viscous substance (B) was prepared.
- a viscous substance (B) was prepared by using 2.7 parts of calcium carbonate, 14.6 parts of sodium alginate as a gelling agent to gel by calcium ions, and 82.7 parts of purified water as water. Then, the obtained granular substance (A) and viscous substance (B) were combined to obtain a composition for preparing a gel for external use of carbon dioxide.
- Porous columnar granules having a length of about 4 mm and a diameter of about lmm were produced by wet extrusion granulation using water, 25 parts of citrate, 25 parts of ethyl cellulose, and 50 parts of croscarmellose sodium. (Production of viscous composition)
- lactose as a water-soluble dispersant
- citric acid as a water-soluble acid
- 7 parts of processed starch as a thickener 3 parts of dextrin
- 3 parts of potato starch 10 parts of wet extrusion granulation using water as a solvent Produced porous columnar granules having a length of about 4 mm and a diameter of about lmm.
- composition for preparing a gel for external use of carbon dioxide of Example and the composition for preparing an external preparation of carbon dioxide of Comparative Example thus obtained were evaluated as follows.
- Example 15 With respect to the composition for preparing an external carbon dioxide gel of Example 15, 1.2 g of a granular substance and 20 g of a viscous substance were mixed 30 times using a plastic spatula to prepare an external carbon dioxide gel.
- composition for preparing a carbon dioxide external preparation of Comparative Example 1 2 g of the granular substance and 30 g of the viscous substance were mixed 30 times using a plastic spatula to prepare a carbon dioxide external preparation.
- composition for preparing a carbon dioxide external preparation of Comparative Example 2 1.4 g of the granular material and 30 g of the viscous composition were mixed 30 times with a spatula in a plastic container to prepare a carbon dioxide external preparation.
- any of the compositions for preparing the gel for external use of carbon dioxide in Examples 15 to 15 mixing of the granular material and the viscous material was easy.
- the granular material is evenly distributed and dissolved in the viscous material, and substantially no bubble carbon dioxide is recognized in the gel, so that a fluid gel having appropriate viscosity, tackiness and flexibility is obtained. Obtained.
- the gel was removed after 15 minutes, but all the gels obtained from the composition for preparing a gel for carbon dioxide for external use of Example 15 were moderately cured to form a hide-opening gel sheet, which could be easily peeled off from the face.
- the subjects became whiter and smoother than before the gel was applied, became transparent and dull.
- a partial thinning effect in which ⁇ was reduced and a lift-up effect in which ⁇ and mouth angle force S were increased were observed in all gels.
- the gel obtained from the composition for preparing an external gel for carbon dioxide of Example 2 was excellent in both usability such as ease of application and ease of peeling, and effects.
- the cooling sensation was maintained, and the above-mentioned cosmetic effect was obtained.
- the composition for preparing a carbon dioxide external preparation of Comparative Example 1 was easy to mix the granular material and the viscous composition, but the obtained carbon dioxide external preparation had many bubbles. The bubbles broke when pressed with a spatula.
- the carbon dioxide external preparation was applied to the ⁇ of the subject, it immediately dropped and fell down immediately after application, and soiled the clothes. Further, although a cooling sensation was felt immediately after the application, the cooling sensation disappeared after about 3 minutes, indicating that the carbon dioxide generation reaction was not persistent. After 15 minutes from the application, the carbon dioxide external preparation was removed, but it could not be removed only by washing with very sticky water, and had to be washed with stone. Some white skin after removal Although it was broken, the partial thinning effect of decreasing ⁇ ⁇ ⁇ and the lift-up effect of raising the mouth angle to ⁇ were not observed.
- the gel for external use of carbon dioxide obtained from the composition for preparing an external carbon dioxide gel of the present invention had a force that could be applied to the entire face even with about 20 g. Even with about 30 g of the external preparation for carbon dioxide obtained from the composition, it was somewhat insufficient to apply it to the entire face so as not to break air bubbles in the external preparation for carbon dioxide.
- the composition for preparing a carbon dioxide external preparation of Comparative Example 2 is easy to mix the granular material and the viscous composition, and the granular material is evenly distributed in the viscous composition and the carbon dioxide is sufficiently generated. Met.
- the obtained external preparation for carbon dioxide did not sag when applied to the ⁇ of the subject.
- Evaluation 2 Partial thinning of arm, whitening, skin effect
- the gel hardened moderately and became a gel sheet with a hydrated mouth, and could be easily peeled off from the upper arm.
- the force decreased by 27.5 cm to 26.5 cm before applying the gel, and the lcm decreased, indicating a partial thinning effect.
- the application area was clearly white and smooth compared to the surrounding skin.
- a gel for topical use of carbon dioxide was prepared using 0.5g of granular material (A) and 7g of a viscous material (B) for the gel for external use preparation in Example 1.
- A granular material
- B a viscous material
- a rash accompanied by redness of 4 cm X 7 cm on the left side of the forehead of a 27-year-old woman 0.5 g of the granular material (A) and 15 g of the viscous material (B) of the composition for preparing a gel for external use of carbon dioxide of Example 4 were added.
- a gel for external use of carbon dioxide was prepared using the mixture and applied for 20 minutes. Immediately after the preparation, the gel was soft and spreadable and easy to apply. Cold sensation at the application site was maintained during application, and itching disappeared. After 20 minutes, the gel was removed. However, the gel hardened moderately to form a gel sheet with a hide opening, and could be easily removed. After removing the gel, the rash redness and roughness disappeared and healed.
- Each carbon dioxide external gel was prepared using 0.2 g of the particulate matter (A) and the viscous substance (B) 3. Og of each of the compositions for preparing a carbon dioxide external gel of Examples 6-9, and the forearm or lower part was prepared. It was applied to the thigh. As a result, in each case, reactions (absorption of skin, feeling of cold, etc.) occurred due to absorption of the generated carbon dioxide.
- each applied gel for external use of carbon dioxide can be spread on the skin and mucous membranes without solidifying within 5 minutes after preparation, the surface solidifies in about 15 to 20 minutes, and a gel in the form of a hide mouth gel sheet 30 minutes later. Once formed, it could be cleanly peeled off the skin, with very good results.
- External carbon dioxide gels were prepared using 0.3 g of the granular material (A) and 3.Og of the viscous material (B) of each of the carbon dioxide external gel preparation compositions of Examples 10-13 and 15-18. It was applied to the forearm or lower leg. As a result, in each case, reactions (absorption of skin, cold feeling, etc.) occurred due to absorption of the generated carbon dioxide.
- each of the gels for external use of carbon dioxide obtained in Examples 10 and 11 was solidified within 30 minutes, and was subjected to hide mouth gel sheeting.
- each of the external carbon dioxide gels obtained in Examples 12, 13, 15-18 can be spread on the skin and mucous membrane without setting within 5 minutes after preparation, and can be expressed in about 15-20 minutes. The surface solidified, and after 30 minutes, a gel in the form of a gel sheet with a mouth opening was formed. Thereafter, the gel could be peeled cleanly from the skin, and very good results were obtained.
- a particulate carbon dioxide external composition was prepared using 0.15 g of the particulate material (A) and the viscous substance (B) 3. Og of the composition for preparing a carbon dioxide external gel of Example 14, and the forearm or lower leg was prepared. was applied to the part. As a result, reactions (absorption of skin, redness, etc.) occurred due to absorption of the generated carbon dioxide. Further, the applied gel for external use of carbon dioxide solidified within 30 minutes, and was subjected to hide mouth gel sheeting.
- Example 19 A carbon dioxide external gel was prepared using the particulate matter (A) 0.2 g and the viscous substance (B) 3. Og of each of the compositions for preparing a carbon dioxide external gel of Example 25, and the forearm. It was applied to the lower leg or lower leg. As a result, in each case, reactions (redness of skin, cold sensation, etc.) occurred due to absorption of the generated carbon dioxide.
- each of the carbon dioxide external preparations obtained in Example 2125 was solidified within 30 minutes, and was covered with a gel at a hide mouth.
- each of the external carbon dioxide gels obtained in Examples 19 and 20 can be spread on the skin and mucous membrane without setting within 5 minutes after preparation, and the surface solidifies in about 15 to 20 minutes. After 30 minutes, a gel in the form of a gel at the mouth of a hide was formed, and then the gel could be peeled cleanly from the skin, and very good results were obtained.
- a carbon dioxide external gel was prepared using 0.3 g of the granular material (A) and 3.Og of the viscous material (B) of each of the compositions for preparing a carbon dioxide external gel of Example 59-59, and the forearm was prepared. It was applied to the lower leg or lower leg. As a result, in each case, reactions (redness of skin, cold sensation, etc.) occurred due to absorption of the generated carbon dioxide.
- Each of the applied gels for external use of carbon dioxide can be spread on the skin and mucous membrane without solidifying within 5 minutes after preparation, the surface solidifies in about 15 to 20 minutes, and the gel sheet for hide mouth after 30 minutes A gel in the form of a gel was formed, after which it could be cleanly removed from the skin, with very good results.
- a carbon dioxide external gel was prepared using 0.3 g of the granular material (A) and 3.Og of the viscous material (B) of each of the compositions for preparing a carbon dioxide external gel of Examples 60 to 69, and the forearm was prepared. It was applied to the lower leg or lower leg. As a result, in each case, reactions (redness of skin, cold sensation, etc.) occurred due to absorption of the generated carbon dioxide.
- each of the external gels for carbon dioxide obtained in Examples 61, 62 and 66-69 solidified within 30 minutes and was formed into a hydrated mouth gel sheet.
- each of the external gels for carbon dioxide obtained in Examples 60 and 63-65 can be spread on the skin and mucous membranes without solidifying within 5 minutes after preparation, and the surface solidifies in about 15-20 minutes. After 30 minutes, a gel in the form of a gel with a mouth opening was formed, and thereafter, it could be peeled off from the skin neatly, and very good results were obtained.
- each of the external carbon dioxide gels obtained in Examples 70-83 and 86 can be spread on the skin and mucous membrane without solidifying within 5 minutes after preparation, and the surface solidifies in about 15 to 20 minutes. After 30 minutes, a gel in the form of a gel with a mouth opening was formed. Thereafter, the gel could be peeled cleanly from the skin, and very good results were obtained.
- Granules of the composition for preparing a gel for external use of carbon dioxide of Example 88 (A) 0.05 g of viscous material (B) 1.
- a gel for external use of carbon dioxide was prepared using Og, and the forearm or lower leg was prepared. Was applied to the part.
- reactions (absorption of skin, redness, etc.) occurred due to absorption of the generated carbon dioxide.
- the external carbon dioxide gel obtained in Example 88 solidified within 30 minutes and was converted into a gel sheet with a void.
- a particulate carbon dioxide external composition (A) 0.2 g and a viscous substance (B) 3.A carbon dioxide external gel was prepared using Og. Then, it was applied. Immediately after preparation, the gel was soft and easily spreadable and easy to apply. The coldness of the application area lasted for more than 30 minutes, and the pain disappeared. The gel was moderately cured after 30 minutes to form a hydrated gel sheet, and then protected for more than 6 hours before the sheet was peeled off.
- the gel for external use of carbon dioxide obtained by the composition for preparing a gel for external use of carbon dioxide of the present invention was compared with the kit of JP-A-2000-319187 and the composition of WO02 / 80941.
- a stronger cosmetic or medical effect was obtained in a shorter time, the coating could be applied thinly and uniformly, the coating did not sag, and was easily removed after use.
- a gel for external carbon dioxide in which a large amount of substantially non-bubble carbon dioxide is dissolved in the gel is obtained.
- S power If this external gel for carbon dioxide is used for the skin and mucous membranes, a stronger cosmetic or medical effect can be obtained in a shorter time. Therefore, a desired cosmetic or medical effect can be obtained with a smaller amount and a smaller number of uses. Also, since it is a gel, it does not sag when applied, and is easy to remove after use. Therefore, it can be suitably used as a cosmetic or an external medicine such as a wound dressing.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES04771843T ES2385483T3 (es) | 2003-08-19 | 2004-08-19 | Composiciones para la preparación de un gel de dióxido de carbono para uso externo y geles de dióxido de carbono para uso externo |
JP2005513210A JP4599543B2 (ja) | 2003-08-19 | 2004-08-19 | 二酸化炭素外用ゲル調製用組成物と二酸化炭素外用ゲル |
EP04771843A EP1666020B1 (en) | 2003-08-19 | 2004-08-19 | Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use |
AT04771843T ATE555772T1 (de) | 2003-08-19 | 2004-08-19 | Zusammensetzungen zur herstellung von kohlendioxid-gels zur topischen anwendung und kohlendioxid-gels zur topischen anwendung |
US11/307,710 US20060257504A1 (en) | 2003-08-19 | 2006-02-17 | Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003295443 | 2003-08-19 | ||
JP2003-295443 | 2003-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005016290A1 true WO2005016290A1 (ja) | 2005-02-24 |
Family
ID=34191100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/011882 WO2005016290A1 (ja) | 2003-08-19 | 2004-08-19 | 二酸化炭素外用ゲル調製用組成物と二酸化炭素外用ゲル |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060257504A1 (ja) |
EP (1) | EP1666020B1 (ja) |
JP (1) | JP4599543B2 (ja) |
CN (1) | CN100455278C (ja) |
AT (1) | ATE555772T1 (ja) |
ES (1) | ES2385483T3 (ja) |
TW (1) | TWI330531B (ja) |
WO (1) | WO2005016290A1 (ja) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007112726A (ja) * | 2005-10-19 | 2007-05-10 | Neochemir Inc | 二酸化炭素外用剤剥離除去方法及びそれに用いる二価陽イオン含有水性溶液 |
WO2008156323A2 (en) * | 2007-06-20 | 2008-12-24 | Hyun Pyo Jeon | Pack cosmetic composition controlling carbon dioxide generation |
WO2009054501A1 (ja) | 2007-10-25 | 2009-04-30 | Neochemir Inc. | 筋力増強のための二酸化炭素供給手段の使用、及びそれによる家畜の肉量増量方法 |
WO2012133114A1 (ja) | 2011-03-29 | 2012-10-04 | ネオケミア株式会社 | 二酸化炭素を有効成分とする抗腫瘍剤 |
WO2013011935A1 (ja) | 2011-07-15 | 2013-01-24 | ネオケミア株式会社 | 二酸化炭素を有効成分とする骨折治療剤、骨成長促進剤または骨疾患治療若しくは予防剤 |
WO2014050912A1 (ja) | 2012-09-26 | 2014-04-03 | ネオケミア株式会社 | 二酸化炭素を溶解した液状医薬とそれを用いる治療方法 |
JP2014062087A (ja) * | 2012-09-03 | 2014-04-10 | Daizo:Kk | 塗布用組成物および該塗布用組成物を用いた塗布製品 |
WO2015001964A1 (ja) | 2013-07-04 | 2015-01-08 | ネオケミア株式会社 | 経皮吸収用気体製造装置、経皮吸収用気体製造方法、及び経皮吸収用気体 |
WO2019035405A1 (ja) | 2017-08-17 | 2019-02-21 | 雅也 田中 | 二酸化炭素外用剤 |
WO2022230925A1 (ja) * | 2021-04-28 | 2022-11-03 | アスパック企業株式会社 | 膿皮症改善剤 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI327474B (en) * | 2001-04-06 | 2010-07-21 | Neochemir Inc | Kit for preparation of carbon dioxide agent for external use. |
BRPI0918447A2 (pt) * | 2008-09-12 | 2018-08-28 | Univ Brigham Young | filmes contendo um gás oxigenado infundido e métodos para a sua preparação |
CN102171759B (zh) * | 2008-09-12 | 2017-01-18 | 布莱阿姆青年大学 | 包含碳及金属层的数据存储媒介 |
GB2490516A (en) * | 2011-05-03 | 2012-11-07 | Systagenix Wound Man Ip Co Bv | Polysaccharide mould for wound treatment |
WO2013031030A1 (en) * | 2011-09-01 | 2013-03-07 | L'oreal | Cosmetic sheet |
CN114669181B (zh) * | 2022-03-09 | 2023-01-13 | 中国石油大学(华东) | 基于阴离子囊泡构建促进二氧化碳和水气液传递系统 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000319187A (ja) * | 1999-05-06 | 2000-11-21 | Medion Research Laboratories Inc | 二酸化炭素経皮・経粘膜吸収用組成物 |
WO2002080941A1 (fr) * | 2001-04-06 | 2002-10-17 | Masaya Tanaka | Compositions destinees a preparer des agents exterieurs du dioxyde de carbone |
JP2003073253A (ja) * | 2001-09-04 | 2003-03-12 | Neochemir Inc | 美容方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4678661A (en) * | 1983-09-28 | 1987-07-07 | Gerhard Gergely | Effervescent composition and method of making same |
US4623536A (en) * | 1985-06-13 | 1986-11-18 | Church & Dwight Co., Inc. | Sodium bicarbonate containing toothpaste |
US4948575A (en) * | 1989-01-24 | 1990-08-14 | Minnesota Mining And Manufacturing Company | Alginate hydrogel foam wound dressing |
JP3338715B2 (ja) * | 1992-10-05 | 2002-10-28 | 株式会社コーセー | カプセル含有化粧料 |
US6063406A (en) * | 1997-04-18 | 2000-05-16 | Chemcraft, Inc. | Skin care compositions |
EP1043023B1 (en) * | 1997-11-07 | 2008-07-09 | Medion Research Laboratories Inc. | Viscous compositions containing carbon dioxide |
US6191167B1 (en) * | 1997-12-29 | 2001-02-20 | Tristrata Technology, Inc. | Pharmaceutical compositions containing hydroxycarboxylic acid and/or ketocarboxylic acids and methods of using the same |
TWI345473B (en) * | 2002-07-05 | 2011-07-21 | Neochemir Inc | Carbon dioxide agent for external use and the stuff for preparation of the same |
-
2004
- 2004-08-18 TW TW093124787A patent/TWI330531B/zh not_active IP Right Cessation
- 2004-08-19 JP JP2005513210A patent/JP4599543B2/ja active Active
- 2004-08-19 WO PCT/JP2004/011882 patent/WO2005016290A1/ja active Application Filing
- 2004-08-19 ES ES04771843T patent/ES2385483T3/es active Active
- 2004-08-19 AT AT04771843T patent/ATE555772T1/de active
- 2004-08-19 CN CNB2004800233472A patent/CN100455278C/zh not_active Expired - Fee Related
- 2004-08-19 EP EP04771843A patent/EP1666020B1/en not_active Not-in-force
-
2006
- 2006-02-17 US US11/307,710 patent/US20060257504A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000319187A (ja) * | 1999-05-06 | 2000-11-21 | Medion Research Laboratories Inc | 二酸化炭素経皮・経粘膜吸収用組成物 |
WO2002080941A1 (fr) * | 2001-04-06 | 2002-10-17 | Masaya Tanaka | Compositions destinees a preparer des agents exterieurs du dioxyde de carbone |
JP2003073253A (ja) * | 2001-09-04 | 2003-03-12 | Neochemir Inc | 美容方法 |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007112726A (ja) * | 2005-10-19 | 2007-05-10 | Neochemir Inc | 二酸化炭素外用剤剥離除去方法及びそれに用いる二価陽イオン含有水性溶液 |
WO2008156323A2 (en) * | 2007-06-20 | 2008-12-24 | Hyun Pyo Jeon | Pack cosmetic composition controlling carbon dioxide generation |
WO2008156323A3 (en) * | 2007-06-20 | 2009-03-19 | Hyun Pyo Jeon | Pack cosmetic composition controlling carbon dioxide generation |
WO2009054501A1 (ja) | 2007-10-25 | 2009-04-30 | Neochemir Inc. | 筋力増強のための二酸化炭素供給手段の使用、及びそれによる家畜の肉量増量方法 |
WO2012133114A1 (ja) | 2011-03-29 | 2012-10-04 | ネオケミア株式会社 | 二酸化炭素を有効成分とする抗腫瘍剤 |
JP2015107987A (ja) * | 2011-07-15 | 2015-06-11 | ネオケミア株式会社 | 二酸化炭素を有効成分とする骨折治療剤、骨成長促進剤または骨疾患治療若しくは予防剤 |
WO2013011935A1 (ja) | 2011-07-15 | 2013-01-24 | ネオケミア株式会社 | 二酸化炭素を有効成分とする骨折治療剤、骨成長促進剤または骨疾患治療若しくは予防剤 |
JPWO2013011935A1 (ja) * | 2011-07-15 | 2015-02-23 | ネオケミア株式会社 | 二酸化炭素を有効成分とする骨折治療剤、骨成長促進剤または骨疾患治療若しくは予防剤 |
JP2014062087A (ja) * | 2012-09-03 | 2014-04-10 | Daizo:Kk | 塗布用組成物および該塗布用組成物を用いた塗布製品 |
WO2014050912A1 (ja) | 2012-09-26 | 2014-04-03 | ネオケミア株式会社 | 二酸化炭素を溶解した液状医薬とそれを用いる治療方法 |
WO2015001964A1 (ja) | 2013-07-04 | 2015-01-08 | ネオケミア株式会社 | 経皮吸収用気体製造装置、経皮吸収用気体製造方法、及び経皮吸収用気体 |
KR20160026619A (ko) | 2013-07-04 | 2016-03-09 | 네오케미아 가부시키가이샤 | 경피흡수용 기체 제조장치, 경피흡수용 기체 제조방법, 및 경피흡수용 기체 |
WO2019035405A1 (ja) | 2017-08-17 | 2019-02-21 | 雅也 田中 | 二酸化炭素外用剤 |
KR20200042486A (ko) | 2017-08-17 | 2020-04-23 | 마사야 다나카 | 이산화탄소 외용제 |
US11141394B2 (en) | 2017-08-17 | 2021-10-12 | Masaya Tanaka | Carbon dioxide external preparation |
WO2022230925A1 (ja) * | 2021-04-28 | 2022-11-03 | アスパック企業株式会社 | 膿皮症改善剤 |
Also Published As
Publication number | Publication date |
---|---|
EP1666020A1 (en) | 2006-06-07 |
CN100455278C (zh) | 2009-01-28 |
JP4599543B2 (ja) | 2010-12-15 |
ES2385483T3 (es) | 2012-07-25 |
CN1835726A (zh) | 2006-09-20 |
TW200507860A (en) | 2005-03-01 |
US20060257504A1 (en) | 2006-11-16 |
ATE555772T1 (de) | 2012-05-15 |
EP1666020B1 (en) | 2012-05-02 |
JPWO2005016290A1 (ja) | 2007-11-01 |
TWI330531B (en) | 2010-09-21 |
EP1666020A4 (en) | 2009-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4823296B2 (ja) | 二酸化炭素外用剤調製用組成物 | |
US20060257504A1 (en) | Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use | |
JP4595058B2 (ja) | 二酸化炭素外用剤調製用組成物 | |
JP4838242B2 (ja) | アルギネートを含む多孔性成型品の製造方法 | |
KR101092709B1 (ko) | 이산화탄소 외용제 및 이산화탄소 외용제 조제용 재료 | |
JP2003530424A (ja) | 膜送達システム | |
TWI316858B (en) | Carbon dioxide external composition and method for producing the same | |
RU2326137C2 (ru) | Способ получения содержащих альгинат пористых формованных изделий | |
JP2012149024A (ja) | 二酸化炭素外用剤調製用組成物 | |
CN111700810A (zh) | 使牙釉质再矿化的新型组合物 | |
KR100861171B1 (ko) | 이산화탄소 외용겔 조제용 조성물과 이산화탄소 외용겔 | |
JPWO2004078185A1 (ja) | 二酸化炭素の経皮経粘膜吸収方法および美容方法、並びに治療方法 | |
JP4130181B2 (ja) | 二酸化炭素外用剤調製用組成物 | |
JP3470007B2 (ja) | パック化粧料 | |
JPH1017479A (ja) | 塩含有外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480023347.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005513210 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067003459 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004771843 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004771843 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067003459 Country of ref document: KR |